Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Beta2 integrin/ICAM expression in Crohn's disease

C N Bernstein1, M Sargent, W M Gallatin

  • 1Department of Medicine, University of Manitoba, Winnipeg, Manitoba, R3A 1R9, Canada.

Clinical Immunology and Immunopathology
|March 7, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome.

Familial cancer·2023
Same author

Does conventional early life academic excellence predict later life scientific discovery? An assessment of the lives of great medical innovators.

QJM : monthly journal of the Association of Physicians·2020
Same author

Predictors of patient reluctance to wake early in the morning for bowel preparation for colonoscopy: a precolonoscopy survey in city-wide practice.

Endoscopy international open·2018
Same author

Independent Validation of a Self-Report Version of the IBD Disability Index (IBDDI) in a Population-Based Cohort of IBD Patients.

Inflammatory bowel diseases·2018
Same author

Factors Associated with Anxiety About Colonoscopy: The Preparation, the Procedure, and the Anticipated Findings.

Digestive diseases and sciences·2018
Same author

Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.

Epidemiology and psychiatric sciences·2017

This study investigated beta2 integrins and ICAM molecules in Crohn's disease patients, finding increased expression in the colon and ileum. These findings suggest potential therapeutic targets for inflammatory bowel disease.

Area of Science:

  • Gastroenterology
  • Immunology
  • Cell Biology

Background:

  • Beta2 integrins and ICAM molecules are adhesion molecules involved in inflammatory responses.
  • Their role in Crohn's disease, an inflammatory bowel disease, is not fully understood.

Purpose of the Study:

  • To comprehensively study the expression of beta2 integrins and ICAM molecules in the colon and ileum of patients with Crohn's disease.
  • To compare expression levels with normal tissues and tissues from patients with ulcerative colitis.

Main Methods:

  • Immunohistochemistry was used to analyze CD18, CD11a, CD11b, CD11c, alphad, ICAM-1, ICAM-2, and ICAM-3 expression.
  • Colon and ileum specimens from Crohn's disease patients, normal individuals, and ulcerative colitis patients were examined across different tissue layers.

Related Experiment Videos

Main Results:

  • Increased expression of beta2 integrins was observed in the colon mucosa and submucosa of Crohn's disease patients compared to normal.
  • Mucosal CD11c expression was significantly higher in Crohn's disease than in ulcerative colitis.
  • ICAM-1 and ICAM-2 expression was increased in Crohn's disease colon and ileum compared to normal, with notable upregulation of ICAM-2 in ileal mucosa.

Conclusions:

  • Differential expression of beta2 integrins and ICAM molecules occurs in Crohn's disease.
  • The observed increase in these adhesion molecules may contribute to the inflammatory processes in Crohn's disease.
  • These molecules represent potential targets for future therapeutic interventions.